Anton Neschadim
124 Orchard View Boulevard
Toronto, ON, Canada
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Engineered Thymidine-Active Deoxycytidine Kinase for Bystander Killing of Malignant Cells.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: December 13, 2018
GM-CSF and IL-4 are not involved in IVIG-mediated amelioration of ITP in mice: a role for IL-11 cannot be ruled out.
Journal: Clinical and experimental immunology
Published: April 23, 2018
Engineering Hematopoietic Cells for Cancer Immunotherapy: Strategies to Address Safety and Toxicity Concerns.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: August 05, 2016
Small molecule phagocytosis inhibitors for immune cytopenias.
Journal: Autoimmunity reviews
Published: May 22, 2016
Extracellular histones identified in crocodile blood inhibit in-vitro HIV-1 infection.
Journal: AIDS (London, England)
Published: May 19, 2016
Mouse Models for Immune-Mediated Platelet Destruction or Immune Thrombocytopenia (ITP).
Journal: Current protocols in immunology
Published: April 03, 2016
c-SRC protein tyrosine kinase regulates early HIV-1 infection post-entry.
Journal: AIDS (London, England)
Published: January 26, 2016
Evaluation of Bystander Cell Killing Effects in Suicide Gene Therapy of Cancer: Engineered Thymidylate Kinase (TMPK)/AZT Enzyme-Prodrug Axis.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: June 15, 2015
Mouse models of autoimmune diseases: immune thrombocytopenia.
Journal: Current pharmaceutical design
Published: January 27, 2015
Relaxin receptor antagonist AT-001 synergizes with docetaxel in androgen-independent prostate xenografts.
Journal: Endocrine-related cancer
Published: May 09, 2014
Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: April 25, 2014
Targeting the relaxin hormonal pathway in prostate cancer.
Journal: International journal of cancer
Published: April 12, 2014
Last Updated: 09/26/2026